More Than 9,000 Taxotere Cases Over Long-Term Hair Loss Pending in MDL
Sanofi-Aventis faces more than 9,000 Taxotere hair loss lawsuits in federal court, according to a recent joint report.…
«
»
Sanofi-Aventis faces more than 9,000 Taxotere hair loss lawsuits in federal court, according to a recent joint report.…
A series of five bellwether trials for Taxotere hairloss lawsuits have been scheduled to begin in 2019.…
A new study warns that some chemotherapy drugs may cause a form of nerve damage in child cancer patients.…
A breast implant cancer lawsuit filed against Allergan accuses the company of failing to report post-marketing study results that could have revealed the risk of breast implant-associated lymphoma.…
Investors who wish to join the recently filed Varubi class action lawsuit have until today to file a motion to participate in the claim as a lead plaintiff.…
Four Taxotere hair loss claims have been selected as candidates for the first bellwether trial slated to begin in September.…
A class action lawsuit against the makers of Varubi claims that the manufacturer failed to warn investors of the risks of hypersensitivity reactions, resulting in a steep drop in stock value when the adverse health effects were revealed.…
A statement by the American Heart Association warns of the potential risks of some breast cancer treatments and what healthcare professionals should do to help patients avoid them.…
Lawsuits have been filed on behalf of more than 7,500 women who suffered permanent hair loss from Taxotere, claiming that the manufacturer failed to adequately warn about the risks associated with the breast cancer drug, which is not seen with other, equally effective treatment options.…
The chemotherapy nausea treatment Varubi has been linked to cases of hypersensitivity and anaphylaxis, resulting in a new drug label warning updates.…